Development Level

Tbio 5 | 11,445
Tdark 5 | 6,588
Tclin 2 | 613
Tchem 1 | 1,598

IMPC Phenotype

abnormal behavior 1 | 298
decreased body weight 1 | 161
decreased circulating amylase ... 1 | 28
decreased circulating phosphat... 1 | 27
decreased circulating total pr... 1 | 49
decreased circulating triglyce... 1 | 79
decreased erythrocyte cell num... 1 | 62
decreased hematocrit 1 | 46
decreased hemoglobin content 1 | 68
decreased prepulse inhibition 1 | 82
increased circulating calcium ... 1 | 34
increased fasted circulating g... 1 | 76
increased startle reflex 1 | 112
short tibia 1 | 97
vertebral fusion 1 | 23

Disease

Carcinoma 10 | 11,493
Attention deficit hyperactivity disorder 4 | 278
Cancer 4 | 2,499
Depressive disorder 4 | 409
medulloblastoma, large-cell 4 | 6,241
osteosarcoma 4 | 7,950
ovarian cancer 4 | 8,520
primitive neuroectodermal tumor 4 | 3,035
psoriasis 4 | 6,694
Bipolar Disorder 3 | 666
Hypotension 3 | 82
Parkinson's disease 3 | 392
Schizophrenia 3 | 1,160
Seizures 3 | 596
atypical teratoid / rhabdoid tumor 3 | 5,112
colon cancer 3 | 1,478
group 3 medulloblastoma 3 | 4,104
lung carcinoma 3 | 2,843
non-small cell lung cancer 3 | 2,890
ulcerative colitis 3 | 1,819
Abnormal vision 2 | 52
Acromegaly 2 | 51
Alcohol dependence 2 | 107
Alcoholic Intoxication, Chronic 2 | 289
Amphetamine-Related Disorders 2 | 74
Anxiety 2 | 136
Anxiety disease 2 | 113
Attention Deficit Disorder with Hyperactivity 2 | 21
Catalepsy 2 | 15
Charcot-Marie-Tooth disease dominant intermediate F 2 | 3
Cholera 2 | 34
Cocaine-Related Disorders 2 | 92
Conduct disorder 2 | 33
Congenital Heart Defects 2 | 58
DOID:2415 2 | 5
Dyskinesia, Drug-Induced 2 | 15
Fibrous dysplasia 2 | 15
Gilles de la Tourette syndrome 2 | 47
Heart Defects, Congenital 2 | 37
Heroin dependence 2 | 30
Huntington's disease 2 | 76
Hyperactive behavior 2 | 91
Hyperkinesis 2 | 32
Hyperprolactinemia 2 | 27
Malignant melanoma of choroid 2 | 3
Malignant melanoma of ciliary body 2 | 3
Malignant melanoma of iris 2 | 4
McCune Albright syndrome 2 | 19
Melanoma 2 | 711
Mental Depression 2 | 333
Movement Disorders 2 | 55
Ocular cancer 2 | 7
Organic writer's cramp 2 | 10
Parkinson Disease 2 | 64
Parkinsonism 2 | 18
Pathological gambling 2 | 15
Pertussis 2 | 20
Phakomatosis cesioflammea 2 | 2
Postencephalitic parkinsonism 2 | 12
Pseudohypoparathyroidism 2 | 18
Recurrent depression 2 | 9
Retinal Detachment 2 | 51
Skin cancer 2 | 469
Substance abuse 2 | 59
Torticollis 2 | 18
Uveal melanoma 2 | 20
active Crohn's disease 2 | 922
active ulcerative colitis 2 | 764
adult high grade glioma 2 | 3,801
astrocytoma 2 | 1,146
diabetes mellitus 2 | 1,728
ependymoma 2 | 4,679
glioblastoma 2 | 5,792
group 4 medulloblastoma 2 | 1,855
lung cancer 2 | 4,740
oligodendroglioma 2 | 2,850
pancreatic cancer 2 | 2,398
tuberculosis 2 | 2,010
Abnormal respiratory patterns 1 | 20
Angioedema 1 | 38
Cerebral cortex myoclonus 1 | 3
Congenital arteriovenous malformation 1 | 8
General anesthesia 1 | 53
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1 1 | 2
HYPOCALCEMIA, AUTOSOMAL DOMINANT 2 1 | 1
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II (disorder) 1 | 1
Hypermagnesiuria 1 | 3
Hypocalciuric hypercalcemia, familial, type II 1 | 1
Increased calcium level in kidney 1 | 21
Marijuana Abuse 1 | 31
Myasthenias 1 | 8
Nausea 1 | 20
Obsessive compulsive behavior 1 | 25
Pain 1 | 103
Phakomatosis cesiomarmorata 1 | 1
SERUM PHOSPHATE ELEVATED 1 | 14
Strawberry nevus of skin 1 | 10
Stuttering 1 | 17
Type 2 Diabetes Mellitus Treatment Adjunct 1 | 7
substance-induced psychosis 1 | 8

Tissue

Endocrine System 10 | 18,159
Digestive Tract 8 | 17,369
Female tissues 8 | 17,400
Male tissues 8 | 17,142
Nervous System 8 | 16,725
Respiratory system 8 | 16,393
Liver and Pancreas 7 | 16,750
Skin and soft tissues 7 | 17,230
Blood and immune system 6 | 16,909
Cardiovascular System 6 | 15,192
Urinary Tract 6 | 16,678

Target Family

oGPCR 5 | 421
Non-IDG 4 | 12,091
GPCR 3 | 408
Transporter 1 | 473

GO Process

phospholipase C-activating dop... 13 | 13
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Olfactory receptor 56A5 OR56A5 Tdark oGPCR 0.00000 0
D(2) dopamine receptor DRD2 Tclin GPCR -3.28700 1882.2 264
Guanine nucleotide-binding protein subunit alpha-15 GNA15 Tbio Non-IDG -2.75089 487.7 170